Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects

Journal of the American Society of Nephrology

Volumn 12, Issue 1, 2001, Pages 194-200

  Ecder, T ^a   Schrier, R W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTENSION; KIDNEY CYST; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR;

EID: 0035161149     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Autosomal dominant polycystic kidney disease
2. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease
3. Renal structure and hypertension in autosomal dominant polycystic kidney disease
4. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
5. Causes of death in autosomal dominant polycystic kidney disease
6. Clinical data of polycystic kidney
7. Hypertension in cases of congenital polycystic kidney
8. Congenital polycystic disease of the kidney: Review of the literature, and data on 207 cases
9. Bilateral polycystic disease of the kidneys: A follow-up of two hundred and eighty-four patients and their families
10. Hypertension in polycystic kidney disease
11. Behaviour of arterial pressure in different stages of polycystic kidney disease
12. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings
13. Polycystic kidney disease: Prospective analysis of nonazotemic patients and family members
14. Autosomal dominant polycystic kidney disease in childhood: A longitudinal study
15. The spectrum of autosomal dominant polycystic kidney disease in children
16. The arterial supply of the congenital polycystic kidney and its relation to the clinical picture
17. The importance of selective renal angiography in the diagnosis of polycystic disease
18. Renal histology in polycystic kidney disease with incipient and advanced renal failure
19. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies
20. Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans
21. Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease
22. The anatomy of the renin-secreting cell in adult polycystic kidney disease
23. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease
24. Hypertension in polycystic kidney disease without renal failure
25. Role of the renin-angiotensin system in hypertension of polycystic kidney disease
26. Hypertension of renal origin: Evidence for two different mechanisms
27. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats
28. Hypertension of polycystic kidney disease: Mechanisms and hemodynamic alterations
29. Hypertension in autosomal dominant polycystic kidney disease
30. Venoconstriction may explain increased plasma atrial natriuretic peptide and cardiac output in hypertensive autosomal dominant polycystic kidney disease
31. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease
32. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease
33. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney
34. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease
35. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease
36. Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease
37. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members
38. Alterations in renal tubular sodium and water transport in polycystic kidney disease
39. Exaggerated natriuresis in adult polycystic kidney disease
40. Change in renal tubular sodium and water handling during progression of polycystic kidney disease: Relationship to atrial natriuretic peptide
41. Natriuretic response to volume expansion in polycystic kidney disease
42. Natriuresis-pressure relationship in polycystic kidney disease
43. Sympathetic nervous activity in adult polycystic kidney disease
44. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives
45. The kidney in the pathogenesis of hypertension: The role of renal nerves
46. The neural control of renal function
47. Renal endothelin system in polycystic kidney disease
48. Plasma concentration of endothelin and arterial pressure in patients with ADPKD
49. Influence of hypertension on early renal insufficiency in autosomal dominant polycystic kidney disease
50. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells
51. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
52. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease
53. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease
54. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease
55. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
56. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
57. Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease
58. Rate of functional deterioration in polycystic kidney disease
59. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease
60. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease
61. A long-term comparison of the effects on renal function of BP control with either atenolol or enalapril in polycystic kidney disease
62. Effect on renal function of diuretics versus angiotensin converting enzyme inhibitors in hypertensive patients with autosomal dominant polycystic kidney disease [Abstract]
63. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease
64. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
65. Progress in the blood pressure control in autosomal dominant polycystic kidney disease